Attached files
| file | filename |
|---|---|
| EX-99.2 - MEDTOX SCIENTIFIC INC | ex99-2060911.htm |
| EX-99.1 - MEDTOX SCIENTIFIC INC | ex99-1060911.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 9, 2011
MEDTOX SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
1-11394
|
95-3863205
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
402 West County Road D, St. Paul, Minnesota
|
55112
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (651) 636-7466
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
On Thursday, June 9, 2011, MEDTOX Scientific, Inc. (the Company), held the 2011 Annual Meeting of Stockholders at the Radisson Hotel, 2540 North Cleveland Avenue, Roseville, Minnesota.
At the meeting, the holders of 8,434,684 shares of the Company's Common Stock were represented in person or by proxy, thereby constituting a quorum. The votes cast with respect to each item of business properly presented at the meeting are as follows:
Proposal No. 1: The stockholders elected the following persons to serve on the Board of Directors of the Company for three-year terms or until their respective successors are duly elected and qualified, with the following votes:
Director’s Name For Withheld Broker Non-Votes
Richard J. Braun 6,755,345 128,294 1,533,098
Proposal No. 2: The stockholders approved the ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011, with the following votes:
For Against Abstain Broker Non-Votes
8,345,201 71,118 418 NA
Proposal No. 3: The stockholders approved on an advisory basis the compensation of our named executive officers, with the following votes:
For Against Abstain Broker Non-Votes
6,842,135 35,366 6,138 1,533,098
Proposal No. 4: The stockholders approved on an advisory basis a frequency of three years for holding an advisory vote on the compensation of our named executive officers, with the following votes:
1 Year 2 Years 3 Years Abstain Broker Non-Votes
3,165,886 25,644 3,683,836 8,273 1,533,098
Based on the stockholders’ approval of the Board’s recommendation of three years, the Company has determined to hold an advisory vote on named executive officer compensation every three years.
- 2 -
Item 8.01. Other Events
On June 9, 2011, the Company held its Annual Meeting of Stockholders. The Company’s presentation to stockholders at the meeting is attached as Exhibit 99.1. A 2011 Investor Sheet that provided information on the Company’s strategy, performance, and businesses was available for attendees. The investor sheet is attached as Exhibit 99.2.
Item 9.01. Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
The following exhibits are filed as part of this report:
|
Exhibit No.
|
Description
|
|
|
99.1
|
MEDTOX Scientific, Inc. presentation to stockholders, dated June 9, 2011.
|
|
|
99.2
|
MEDTOX Scientific, Inc. 2011 Investor Sheet.
|
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDTOX Scientific, Inc.
Date: June 15, 2011 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer
- 4 -
INDEX TO EXHIBITS
|
Exhibit No.
|
Description
|
|
|
99.1
|
MEDTOX Scientific, Inc. presentation to stockholders, dated June 9, 2011.
|
|
|
99.2
|
MEDTOX Scientific, Inc. 2011 Investor Sheet.
|
- 5 -